Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Expression and prognostic value of glucose transporters and hexokinases in tonsil and mobile tongue squamous cell carcinoma.

Deron P, Vermeersch H, Mees G, Vangestel C, Pauwels P, Van de Wiele C.

Histol Histopathol. 2011 Sep;26(9):1165-72. doi: 10.14670/HH-26.1165.

PMID:
21751148
2.

Expression of glucose transporter-1, hexokinase-II, proliferating cell nuclear antigen and survival of patients with pancreatic cancer.

Lyshchik A, Higashi T, Hara T, Nakamoto Y, Fujimoto K, Doi R, Imamura M, Saga T, Togashi K.

Cancer Invest. 2007 Apr-May;25(3):154-62.

PMID:
17530485
3.

Expression of glucose transporters and hexokinase II in cholangiocellular carcinoma compared using [18F]-2-fluro-2-deoxy-D-glucose positron emission tomography.

Paudyal B, Oriuchi N, Paudyal P, Higuchi T, Nakajima T, Endo K.

Cancer Sci. 2008 Feb;99(2):260-6. doi: 10.1111/j.1349-7006.2007.00683.x.

4.

FDG uptake in primary squamous cell carcinoma of the head and neck. The relationship between overexpression of glucose transporters and hexokinases, tumour proliferation and apoptosis.

Deron P, Vangestel C, Goethals I, De Potter A, Peeters M, Vermeersch H, Van de Wiele C.

Nuklearmedizin. 2011;50(1):15-21. doi: 10.3413/nukmed-0324-10-06. Epub 2010 Nov 5.

PMID:
21052609
5.

Expression of hexokinases and glucose transporters in treated and untreated oesophageal adenocarcinoma.

Fonteyne P, Casneuf V, Pauwels P, Van Damme N, Peeters M, Dierckx R, Van de Wiele C.

Histol Histopathol. 2009 Aug;24(8):971-7. doi: 10.14670/HH-24.971.

PMID:
19554504
6.

Clinical implication of glucose transport and metabolism evaluated by 18F-FDG PET in hepatocellular carcinoma.

Paudyal B, Paudyal P, Oriuchi N, Tsushima Y, Nakajima T, Endo K.

Int J Oncol. 2008 Nov;33(5):1047-54.

PMID:
18949368
7.

Expressions of glucose transporter Types 1 and 3 and hexokinase-II in diffuse large B-cell lymphoma and other B-cell non-Hodgkin's lymphomas.

Shim HK, Lee WW, Park SY, Kim H, So Y, Kim SE.

Nucl Med Biol. 2009 Feb;36(2):191-7. doi: 10.1016/j.nucmedbio.2008.11.009.

PMID:
19217531
8.

Evaluation of cannabinoid CB1 and CB2 receptors expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients' survival.

Theocharis S, Giaginis C, Alexandrou P, Rodriguez J, Tasoulas J, Danas E, Patsouris E, Klijanienko J.

Tumour Biol. 2016 Mar;37(3):3647-56. doi: 10.1007/s13277-015-4182-8. Epub 2015 Oct 12.

PMID:
26459312
9.

The prognostic value of hypoxia markers in T2-staged oral tongue cancer.

Roh JL, Cho KJ, Kwon GY, Ryu CH, Chang HW, Choi SH, Nam SY, Kim SY.

Oral Oncol. 2009 Jan;45(1):63-8. doi: 10.1016/j.oraloncology.2008.03.017. Epub 2008 Jul 11.

PMID:
18620902
10.

Correlation of metabolism/hypoxia markers and fluorodeoxyglucose uptake in oral squamous cell carcinomas.

Yamada T, Uchida M, Kwang-Lee K, Kitamura N, Yoshimura T, Sasabe E, Yamamoto T.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2012 Apr;113(4):464-71. doi: 10.1016/j.tripleo.2011.04.006. Epub 2011 Jul 20.

PMID:
22676927
11.

Relationship between retention index in dual-phase (18)F-FDG PET, and hexokinase-II and glucose transporter-1 expression in pancreatic cancer.

Higashi T, Saga T, Nakamoto Y, Ishimori T, Mamede MH, Wada M, Doi R, Hosotani R, Imamura M, Konishi J.

J Nucl Med. 2002 Feb;43(2):173-80.

12.

The prognostic value of endogenous hypoxia-related markers for head and neck squamous cell carcinomas treated with ARCON.

Jonathan RA, Wijffels KI, Peeters W, de Wilde PC, Marres HA, Merkx MA, Oosterwijk E, van der Kogel AJ, Kaanders JH.

Radiother Oncol. 2006 Jun;79(3):288-97. Epub 2006 May 26.

PMID:
16730088
13.

Biologic correlates of intratumoral heterogeneity in 18F-FDG distribution with regional expression of glucose transporters and hexokinase-II in experimental tumor.

Zhao S, Kuge Y, Mochizuki T, Takahashi T, Nakada K, Sato M, Takei T, Tamaki N.

J Nucl Med. 2005 Apr;46(4):675-82.

14.

Reciprocal immunohistochemical expression of sodium/iodide symporter and hexokinase I in primary thyroid tumors with synchronous cervical metastasis.

Jung YH, Hah JH, Sung MW, Kim KH, Cho SY, Jeon YK.

Laryngoscope. 2009 Mar;119(3):541-8. doi: 10.1002/lary.20073.

PMID:
19235753
15.

Distribution of Hypoxia-Inducible Factor-1α and Glucose Transporter-1 in Human Tongue Cancers.

Vasconcelos MG, Vasconcelos RG, Pereira de Oliveira DH, de Moura Santos E, Pinto LP, da Silveira ÉJ, Queiroz LM.

J Oral Maxillofac Surg. 2015 Sep;73(9):1753-60. doi: 10.1016/j.joms.2015.03.013. Epub 2015 Mar 18.

PMID:
25863229
16.

Correlation between FDG uptake by PET/CT and the expressions of glucose transporter type 1 and hexokinase II in cervical cancer.

Tong SY, Lee JM, Ki KD, Choi YJ, Seol HJ, Lee SK, Huh CY, Kim GY, Lim SJ.

Int J Gynecol Cancer. 2012 May;22(4):654-8. doi: 10.1097/IGC.0b013e31824864e6.

PMID:
22398711
17.

CD147 and Ki-67 overexpression confers poor prognosis in squamous cell carcinoma of oral tongue: a tissue microarray study.

Yu YH, Morales J, Feng L, Lee JJ, El-Naggar AK, Vigneswaran N.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2015 May;119(5):553-65. doi: 10.1016/j.oooo.2014.12.022. Epub 2015 Jan 7.

18.

Overexpression of phosphorylated nuclear factor-kappa B in tonsillar squamous cell carcinoma and high-grade dysplasia is associated with poor prognosis.

Zhang PL, Pellitteri PK, Law A, Gilroy PA, Wood GC, Kennedy TL, Blasick TM, Lun M, Schuerch C 3rd, Brown RE.

Mod Pathol. 2005 Jul;18(7):924-32.

19.

Metallothionein expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patient survival.

Theocharis S, Klijanienko J, Giaginis C, Rodriguez J, Jouffroy T, Girod A, Point D, Tsourouflis G, Sastre-Garau X.

Histopathology. 2011 Sep;59(3):514-25. doi: 10.1111/j.1365-2559.2011.03947.x.

PMID:
22034891
20.

Ephrin receptor (Eph) -A1, -A2, -A4 and -A7 expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival.

Theocharis S, Klijanienko J, Giaginis C, Alexandrou P, Patsouris E, Sastre-Garau X.

Pathol Oncol Res. 2014 Apr;20(2):277-84. doi: 10.1007/s12253-013-9692-3. Epub 2013 Sep 11.

PMID:
24022400

Supplemental Content

Support Center